Fig. 2From: Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populationsCumulative incidence of medication for opioid use disorder (MOUD) initiation by baseline stimulant use overall and stratified by CTN study (N = 673; n = 570 X:BOT and n = 103 CHOICES)Back to article page